Algernon Pharmaceuticals, Inc. engages in the innovation of specialized mass spectrometry. It involves in the development of commercially viable methods such as of breath analysis screening technologies for the early screening of diseases such as lung, breast cancers, neurodegenerative diseases, tuberculosis, diabetes, liver diseases, and others. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Company profile
Ticker
AGNPF, AGN
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Former names
Breathtec BioMedical, Inc., Breathtec Biomedical, Inc.
SEC CIK
AGNPF stock data
Latest filings (excl ownership)
D
$12.56 k in equity, sold $12.56 k, 1 investor
10 Apr 24
RW
Registration withdrawal request
21 Dec 22
F-1/A
Registration statement (foreign) (amended)
2 Jun 22
FWP
Free writing prospectus
10 May 22
F-1/A
Registration statement (foreign) (amended)
9 May 22
F-1/A
Registration statement (foreign) (amended)
25 Apr 22
F-1/A
Registration statement (foreign) (amended)
14 Apr 22
F-1/A
Registration statement (foreign) (amended)
6 Apr 22
F-1/A
Registration statement (foreign) (amended)
23 Mar 22
F-1
Registration statement (foreign)
18 Feb 22
Latest ownership filings
No filings
Institutional ownership, Q3 2021
1.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 21.33 mm |
Total shares | 300.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
RPg Family Wealth Advisory | 300.00 k | $21.33 mm |
Press releases
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
24 Apr 24
Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
11 Apr 24